This API provides live access to the CKAN portion of the Open Government Portal and Registry systems. ### Portal: https://open.canada.ca * Our public data portal * Includes data federated from provinces and municipalities * Read-only API calls can be made without an API key * Authorization required only for publishing federated data ### Registry: https://registry.open.canada.ca * Accessible within the Government of Canada (GoC) network for collecting and publishing data from GoC departments * New datasets must be manually reviewed and approved by the Open Government team * Publishes approved datasets to the Production Portal automatically * User account or API key required for all operations

The Canadian Nutrient File (CNF) is the standard reference food composition database reporting the amount of nutrients in foods commonly consumed in Canada.

Getting comfortable with APIs by: understanding how they work; learn how they are used; and gain experience using them.

Statistics Canada has developed a Web Data Service that provides access to data and metadata that we release each business day. This is a good option for users who want to consume a discrete amount of data points updates to Statistics Canada data. To obtain information on how to use and consume our Web Data Service, please read the Web Data Service User Guide.

Statistics Canada has developed a Web Data Service that provides access to data and metadata that we release each business day. This is a good option for users who want to consume a discrete amount of data points updates to Statistics Canada data. To obtain information on how to use and consume our Web Data Service, please read the Web Data Service User Guide.

The Reference Data as a Service (RDaaS) API provides a list of codesets, classifications, and concordances that are used within Statistics Canada. These resources are shared to help harmonize data, enabling better interdepartmental data integration and analysis. This dataset provides an updated version of the StatCan RDaaS API specification, originally part of the Government of Canada’s GC API Store, which permanently closed on September 29th, 2023. The archived version of the original API specification can be accessed via the Wayback Machine . The specification has been updated to the OpenAPI 3.0 (Swagger 3) standard, enabling use of current tools and features for API exploration and integration. Key interactive features of the updated specification include: * Try-It-Out Functionality: Allows a user to interact with API endpoints directly from the documentation in their browser, submitting test requests and viewing live responses. * Interactive Parameter Input: Simplifies experimentation with filters and parameters to explore API behavior. * Schema Visualization: Provides clear representations of request and response structures.

A Global API for car number plate lookups. Our API is a .NET ASMX webservice, that allows you connect from any programming environment, either .NET (C#, Visual Basic .NET), or through any programming language that supports SOAP (PHP nuSoap, Python, Ruby, Java etc.). Register for free and we will set you up with a test account, where you can make 10 vehicle lookups for free. If you require higher volume of lookups, then our fee is C$ 0.25 per lookup, purchased in blocks of a minimum of 100, a 10% discount is available for packages over 1000.

The NOC is issued to a manufacturer following the satisfactory review of a submission for a new drug, and signifies compliance with the Food and Drug Regulations. The database is updated nightly and contains NOC information on human drugs from January 1, 1994 to date. It also contains NOC information on Veterinary drugs from September 19, 2000 to date.

Snapshot img

API Management Market Size 2025-2029

The API management market size is forecast to increase by USD 3.75 billion at a CAGR of 12.3% between 2024 and 2029.

The market is experiencing significant growth, driven by the increasing adoption of digital payment solutions and the proliferation of digital wallets. However, challenges persist, including poor internet connectivity in developing countries, which can hinder the adoption and effective implementation of Api Management solutions. Companies must navigate these challenges to capitalize on the market's potential. Strategies such as investing in offline solutions and partnering with local providers can help overcome connectivity issues and expand market reach.
Additionally, focusing on security and scalability will be crucial, as businesses demand reliable and secure Api Management solutions to support their digital initiatives. These trends reflect the digital transformation underway in various industries, as businesses seek to enhance customer experience and streamline operations. Overall, the market presents opportunities for innovation and growth, with companies that address the unique challenges of this dynamic landscape poised to succeed.

What will be the Size of the API Management Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The market is experiencing significant innovation, with a focus on enhancing API Return on Investment (ROI) through multi-cloud API adoption and API-driven development. API maturity is on the rise, driving the need for advanced API logging, performance benchmarking, and usage analytics. API interoperability and standardization are crucial to addressing integration challenges in complex API ecosystems. API observability and developer experience are becoming key differentiators, with the emergence of API documentation generators and debugging tools. API adoption rates continue to grow, fueled by the increasing use of composite and hybrid cloud APIs, serverless functions, and microservices orchestration.

The market is experiencing significant growth, driven by the increasing adoption of digital payment solutions and the proliferation of digital wallets. API platform comparisons and compliance are essential for businesses navigating the diverse landscape of API offerings. API monetization strategies, such as API-led connectivity and edge computing APIs, are gaining traction. API evolution is ongoing, with a shift towards API-first design and headless CMS integration. API usage patterns are evolving, requiring new testing frameworks and security measures to address API performance optimization and vulnerabilities. Ultimately, API governance policies and discovery tools are essential for managing the complexities of API consumption and ensuring compliance in the dynamic API market.

How is this API Management Industry segmented?

The api management industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Deployment

  Cloud
  On-premises


Solution

  API gateways
  API lifecycle management
  API security
  API analytics and monitoring
  API developer portals


End-user

  Large enterprises
  SMEs


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    UK


  Middle East and Africa

    UAE


  APAC

    China
    India
    Japan


  South America

    Brazil


  Rest of World (ROW)

By Deployment Insights

The cloud segment is estimated to witness significant growth during the forecast period. The market is experiencing significant growth, driven by the digital transformation sweeping across industries. Cloud-based API solutions dominate the market, enabling seamless communication and data transfer between applications and the cloud. This segment's dominance is attributed to the proliferation of IoT and Big Data, which enhance application interfaces for superior customer experiences. Additionally, the increasing awareness of security vulnerabilities and the demand for automation have fueled the market's expansion in sectors like BFSI, e-commerce, healthcare and life sciences, education, and retail. Cloud APIs facilitate the integration of various cloud and on-premises applications, simplifying API provisioning, activation, setup, monitoring, and troubleshooting for developers and administrators.

Agile development methodologies, such as DevOps and CI/CD, have further accelerated the adoption of cloud APIs. APIs have become essential components of modern application architectures, including microservices, event-driven, and real-time systems. GraphQL APIs and service meshes have emer

BC Parks data is available through the BC Parks API. The data contains information on provincial parks, conservation areas, and ecological reserves. This includes detailed descriptions of protected areas, available activities, amenities, park status, etc. BC Parks API is an open REST and GraphQL API web service providing access to a centralized compilation of current data related to provincial parks in B.C. The data are accessible via the BC Parks API are licensed under the Open Government License - BC. The API itself is licensed under the API Terms of Use (see related links, API Terms of Use). For more information, please see the BC Parks API console or GraphQL Playground.

Our North America Point of Interest (POI) data supports various location intelligence projects and facilitates the development of precise mapping and navigation tools, location analysis, address validation, and much more. Gain access to highly accurate, clean, and North America scaled POI data featuring over 28 million verified locations across 2 countries. We have been providing this data to companies worldwide for 30 years.

• Develop mapping and navigation tools and software.
• Identify new areas and locations suitable for business development.
• Analyze the presence of competitors and nearby populations.
• Optimize routes to enhance delivery efficiency.
• Evaluate property values based on nearby infrastructure.
• Support disaster management by identifying high-risk areas.
• Promote your products and services using geotargeting strategies.

Our use cases demonstrate how our data has been beneficial and helped our customers in several key areas: 1. Gaining a Competitive Edge: Utilize point of interest (POI) data to analyze competitors, identify high-opportunity areas, and attract more customers. 2. Enhancing Customer Journeys: Leverage location intelligence to provide personalized, real-time recommendations that boost customer engagement. 3. Optimizing Store Expansion: Select the most profitable locations by analyzing foot traffic, demographics, and competitor insights. 4. Streamlining Deliveries: Improve fulfillment accuracy through address validation, reducing failed shipments and increasing customer satisfaction. 5. Driving Smarter Campaigns: Use geospatial insights to effectively target the right audiences, enhance outreach, and maximize campaign impact.

This API provides live access to the CKAN portion of the Open Government Portal and Registry systems.

Snapshot img

Small Molecule API Market Size 2024-2028

The small molecule API market size is forecast to increase by USD 67.3 billion at a CAGR of 7.5% between 2023 and 2028.

The market is experiencing significant changes, driven by the shifting landscape of drug development and manufacturing. In developing countries, the small-molecule API manufacturing scenario is evolving, offering cost advantages to contract manufacturers. The increasing geriatric population is fueling demand for small molecule APIs in various therapeutic areas, including diabetes and cancer treatments.
However, high investment costs and the risk of substantial financial losses are major challenges. Pharmaceutical companies are responding by adopting different manufacturing strategies, such as captive manufacturing and merchant manufacturing, to mitigate risks and optimize costs. Biologics and branded drugs continue to dominate the market, but the trend towards generic drugs is gaining momentum. This dynamic market requires continuous monitoring and strategic planning from industry players to stay competitive.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The small molecule Active Pharmaceutical Ingredients (API) market is a significant segment within the pharmaceutical industry, supplying essential components for drug formulation in various therapeutic areas. This market is driven by several factors, including patent expiry of branded drugs, advancements in the drug development process, and the increasing demand for specialty medicines. Raw materials play a crucial role in the synthesis of APIs. Novel technologies, such as computational modeling and natural extraction, are being employed to improve the efficiency and sustainability of chemical synthesis. Contract manufacturers have been increasingly adopting these technologies to cater to the growing demand for APIs in the pharmaceutical sector.
Additionally, the drug development process involves several stages, including discovery, development, and commercialization. The API stage is a critical component of this process, as it directly impacts the efficacy and safety of the final drug product. In the context of small molecule APIs, synthetic methods are widely used to produce these ingredients. The therapeutic areas that witness high demand for small molecule APIs include oncology, cardiovascular diseases, diabetes, and chronic diseases. The increasing prevalence of these diseases and the need for effective treatments have fueled the growth of the market. Biotechnology and natural extraction are alternative methods for producing APIs.
Also, biotechnology involves the use of living organisms to produce therapeutic proteins and other complex molecules, while natural extraction is the process of extracting active compounds from natural sources. Both methods have their advantages and limitations and are used depending on the specific therapeutic area and the nature of the API. Branded drugs and generic drugs differ in their regulatory requirements and market positioning. Branded drugs are innovative treatments with patent protection, while generic drugs are copies of existing drugs with the same active ingredient but different branding and pricing. Captive manufacturing is a strategy employed by some pharmaceutical companies to ensure a consistent supply of APIs for their branded drugs. In conclusion, the market is a dynamic and evolving sector within the pharmaceutical industry. Patent expiry, advancements in the drug development process, and the increasing demand for specialty medicines are some of the key drivers of this market. The use of novel technologies, such as computational modeling and natural extraction, and the adoption of synthetic methods are essential to meet the growing demand for APIs in various therapeutic areas.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Deployment

  Captive APIs
  Contract APIs


Geography

  North America

    Canada
    US


  Asia

    China
    India
    Japan
    South Korea


  Europe

    Germany
    UK
    France
    Italy


  Rest of World (ROW)

By Deployment Insights

The captive APIs segment is estimated to witness significant growth during the forecast period.

The market experienced significant growth in 2023, with the captive API manufacturing segment holding the largest share. The expanding healthcare sector in the United States has fueled this growth, as there is a heightened emphasis on making healthcare services more accessible and affordable. This demand for affordable medicines has resulted in an increased need for low-cost small molecule APIs, which are essentia

BC Parks data is available through the BC Parks API. The data contains information on provincial parks, conservation areas, and ecological reserves. This includes detailed descriptions of protected areas, available activities, amenities, park status, etc. BC Parks API is an open REST and GraphQL API web service providing access to a centralized compilation of current data related to provincial parks in B.C. The data are accessible via the BC Parks API are licensed under the Open Government License - BC. The API itself is licensed under the API Terms of Use (see related links, API Terms of Use). For more information, please see the BC Parks API console or GraphQL Playground.

Interactive map that lists major traffic obstacles on the Repentigny road network.**This third party metadata element was translated using an automated translation tool (Amazon Translate).**

Kaz Canada Inc Company Export Import Records. Follow the Eximpedia platform for HS code, importer-exporter records, and customs shipment details.

Documents on the Summary Basis of Decision (SBD) explain why certain drugs and medical devices were authorized for sale in Canada. Regulatory Decision Summaries (RDS) explain decisions for certain health products seeking market authorization, including medical devices and prescription drugs. A Summary Safety Review (SSR) follows after a potential safety issue with a drug or health product has been identified.

Timexim Canada Inc Company Export Import Records. Follow the Eximpedia platform for HS code, importer-exporter records, and customs shipment details.

Floordi Canada Inc Company Export Import Records. Follow the Eximpedia platform for HS code, importer-exporter records, and customs shipment details.

Snapshot img

Active Pharmaceutical Ingredients Market Size 2025-2029

The active pharmaceutical ingredients market size is forecast to increase by USD 97.6 billion at a CAGR of 7.1% between 2024 and 2029.

The API market is experiencing significant shifts in manufacturing scenarios, with an increasing trend towards outsourcing and locating production facilities in developing countries to reduce costs. Key drivers of the API market include the growing demand for generic drugs, increasing healthcare expenditures, and technological advancements in API manufacturing processes. This paradigm shift, however, comes with its challenges. One of the most pressing issues is the high investment cost associated with setting up and maintaining API manufacturing facilities. The risk of substantial losses in pharmaceutical contract research and manufacturing due to regulatory non-compliance or production errors further complicates matters.. These challenges necessitate strategic planning and effective risk management for companies looking to capitalize on the opportunities presented by the evolving API market.
By carefully evaluating potential manufacturing locations, implementing robust quality control measures, and collaborating with reputable partners, companies can mitigate risks and optimize their operations in this dynamic market.

What will be the size of the API Market during the forecast period?

Request Free Sample

The active pharmaceutical ingredients market continues to evolve, driven by the dynamic interplay of various factors. Drug intermediates serve as the foundation for API synthesis, with ongoing process development efforts leading to more efficient and cost-effective production methods. Pharmacodynamic studies provide valuable insights into the mechanisms of action, guiding drug development and informing regulatory compliance. API suppliers play a crucial role in the supply chain, ensuring the delivery of high-quality pharmaceutical grade bulk drug substances. Biotech companies and pharmaceutical firms collaborate in drug discovery, leveraging advanced technologies such as microbial contamination control and stability studies to optimize formulation development. The demand for APIs is further fueled by research and investment in biologics and biosimilars, as well as small and large molecule drugs for treating various conditions, including infectious diseases, genetic disorders, and mental health disorders like schizophrenia.
Regulatory compliance, including pharmaceutical regulations and quality control measures, remains a significant focus, with analytical chemistry and particle size analysis playing essential roles in ensuring regulatory compliance and maintaining product consistency. Specialty pharmaceuticals and pricing strategies continue to shape the industry landscape, with cost of goods and pricing pressures influencing market dynamics. In the realm of biopharmaceutical manufacturing, continuous process optimization and innovation in drug delivery systems are key drivers. Pharmaceutical regulations and sterility testing are critical components of the manufacturing process, ensuring the production of safe and effective APIs. The API market's continuous evolution reflects the ongoing unfolding of market activities and evolving patterns.
From pharmacokinetic studies and regulatory compliance to API synthesis and drug delivery, the interconnected nature of these elements shapes the industry's future trajectory.

How is this Active Pharmaceutical Ingredients Industry segmented?

The active pharmaceutical ingredients industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Manufacturing Type

  Captive APIs
  Contract APIs


Type

  Innovative APIs
  Generic APIs


Synthesis Method

  Biotech APIs
  Synthetic APIs


Application

  Cardiovascular Diseases
  Oncology
  CNS and Neurology
  Orthopedic
  Endocrinology
  Pulmonology
  Gastroenterology
  Nephrology
  Ophthalmology
  Anti-Infectives
  Diabetes
  Respiratory Diseases
  Other


End-User

  Pharmaceutical Companies
  Biotechnology Companies
  Contract Research Organizations (CROs)
  Academic/Research Institutes


Potency

  High Potency APIs (HPAPIs)
  Low Potency APIs


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  Middle East and Africa

    UAE


  APAC

    China
    India
    Japan


  South America

    Brazil


  Rest of World (ROW)

By Manufacturing Type Insights

The captive apis segment is estimated to witness significant growth during the forecast period.

The captive APIs segment led the global active pharmaceutical ingredients market in 2024, driven by rising healthcare services adoption. Demand for af